May 2, 2019
Celgene and bluebird bio happy with expansion and persistence ofthe CAR T-cells seen in Phase 1 Study
Cellgene and bluebird bio are are encouraged by the expansion and persistence ofthe CAR T-cells, as well as the deep and durable responses with amanageable safety profile we’ve seen for bb2121 to date